Abstract. Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell lymphoma, known to express CD3 and CD4, and, frequently, also CD10 and c-Maf-1. Hypergammaglobulinemia is not particularly rare in patients with AITL. However, AITL in conjunction with plasmacytosis in the peripheral blood is rare. The current report presents a case of CD10-negative AITL demonstrating leukemic change and plasmacytosis in the peripheral blood mimicking plasma cell leukemia. A 78-year-old male was admitted to hospital due to systemic lymph node enlargement, high serum IgG and IgA, and increased counts of plasmacytoid cells and lymphoid cells with atypical nuclei in the peripheral blood. Initially, plasma cell leukemia was suspected, due to the extreme increase in the number of plasma cells in the peripheral blood. However, the plasma cells did not show clonal expansion on examination by flow cytometry. Based on histological analyses, following a biopsy of an enlarged lymph node, the patient was diagnosed with AITL. This case suggests that when hypergammaglobulinemia and increases in B-lineage cells are observed, AITL should be considered in addition to disorders of B-lineage cells.
Introduction
AITL is the second most frequent subtype of peripheral T cell lymphoma in the Western world, accounting for ~25-30% of peripheral T cell lymphoma cases and 2-4% of all cases of lymphoma (1) . It has been reported that AITL presents with a number of clinical symptoms, including fever, weight loss, chills, skin rashes, pruritis, lymphadenopathy, hepatosplenomegaly, anemia, thrombocytopenia and hypergammaglobulinemia (2) . Patients with AITL, frequently exhibit anemia, thrombocytopenia and lymphopenia in the peripheral blood. However, it is rare for patients with AITL to have numerous plasma cells in the peripheral blood, which is a feature more typical of plasma cell leukemia (3) (4) (5) . The current report presents a case of a patient with AITL, in whom leukemic change and plasmacytosis were observed in the peripheral blood, bone marrow and lymph nodes.
Case report
A 78-year-old male was admitted to hospital, due to systemic lymph node swelling and an elevated number of white blood cells in comparison with normal levels, which had been detected by his family doctor 10 days previously. Upon physical examination, lymph nodes in the cervical region, supraclavicular fossa, axillary fossa and inguinal fossa were found to be enlarged to 40 mm. The peripheral white blood cell count was elevated and numerous plasmacytoid cells without dysmorphic features, in addition to small-to-medium-sized lymphoid cells with atypical nuclei, were observed in his peripheral blood, as shown in Table I , Fig. 1 and Fig. 2A and B. 'Other' in the leukocyte classification in Table I , includes plasmacytoid cells (19% of whole white blood cells) and lymphoid cells with nuclear atypia (22% of whole white blood cells). Anemia and low platelet numbers were also observed. Standard levels are noted in parentheses. In the May-Giemsa stained smear specimens of the bone marrow, small-to-medium-sized lymphoid cells with nuclear atypia were found (data not shown). The cells were similar to the small to medium sized lymphoid cells with nuclear atypia observed in the peripheral blood.
Subsequently, biopsies of an enlarged inguinal lymph node were taken. The normal architecture of the lymph node had been replaced by variously-sized, although predominantly medium-sized, lymphoid cells with clear cytoplasm, as shown in Fig. 2E and F. High endothelial venules were prominent (Fig. 2F) (Fig. 4B) . As shown in Fig. 4C , even in the lymph node, the percentage of CD38 + cells had 
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A risen to 28.5%. These cells did not express CD20, while 77% expressed CD19, and ~50% of expressed CD138. Unlike the peripheral blood and bone marrow samples, the CD38 + cells in the lymph node sample expressed MPC-1 and CD45, suggesting an increase in mature plasma cells in the lymph node. The majority of cells expressed cytoplasmic Ig light chain, although the κ:λ ratio did not indicate clonal expansion.
Immunohistological analyses demonstrated a diffuse increase in CD138 + cells and CD3 + cells (T cells) within the lymph node specimen (Fig. 5) . Among T cells, the number of CD4 + cells was markedly increased. Numerous Maf-1 + cells were observed in the lymph node, in addition to a diffuse distribution of Epstein-Barr virus (EBV)-encoded small RNA-positive cells.
In order to examine the clonal rearrangement of T cell receptor (TCR) and Ig, a PCR assay was conducted, as described in the European BIOMED-2 collaborative study (6) . PCR indicated the presence of clonal rearrangements of TCR and Ig (data not shown).
Based on the histological features of the lymph node, the patient's symptoms, the increase in B-lineage cells without neoplastic light chain expression, the increase in CD4 + T cells with clear cytoplasm expressing Maf-1, and the presence of EBV-infected lymphoid cells, the patient was diagnosed with AITL with leukemic change. Following diagnosis, the patient died unexpectedly. No autopsy was permitted, and the exact cause of death therefore remains unclear, although hyperviscosity of the blood may have been a contributing factor. The family of the patient provided informed consent for the publication of this report.
Discussion
The current report discusses the case of a patient with CD10 -AITL with leukemic change, plasmacytosis mimicking plasma cell leukemia and polyclonal hypergammaglobulinemia.
Examination of a lymph node biopsy demonstrated a histology typical of AITL, including completely effaced nodal architecture and the infiltration of medium-sized lymphocytes with clear cytoplasm, in addition to an inflammatory background. Furthermore, increased numbers of plasma cells and lymphoid cells with atypical nuclei were observed in the peripheral blood.
Plasma cell leukemia is defined as circulating peripheral blood plasma cells exceeding 2x10 9 /l or 20% of peripheral white blood cells (7) . In addition, the clonality of these plasma cells may be demonstrated by serum protein electrophoresis, flow cytometric analyses and/or Ig rearrangement. In the present case, 6.308x10 9 /l and 19% of peripheral white blood cells were plasmacytoid cells. The serum γ-globulin was significantly elevated, while serum protein electrophoresis and flow cytometric analyses did not demonstrate any clonal proliferation of B-lineage cells.
The presence of plasmacytoid cells in the peripheral blood is occasionally observed during reactive processes, such as bacterial and viral infections, such as parvovirus B19, hepatitis or EBV; autoimmune disease, such as rheumatoid arthritis, systemic lupus erythematosus or Sjögren's syndrome; and serum sickness. However, in these conditions, the plasmacytoid cell counts are usually not notably elevated (8) (9) (10) (11) (12) (13) (14) (15) (16) .
A number of cases of AITL with increased plasmacytoid cells in the peripheral blood, which is typical of plasma cell leukemia, have been reported (3) (4) (5) . In these reports, the plasmacytoid cell counts in the peripheral blood were markedly elevated, although they did not exhibit clonal expansion. These reports were in accordance with the findings in the present case. In the case reported here, small-to-medium-sized lymphoid cells with atypical nuclei were also observed in the peripheral blood, and flow cytometric analyses demonstrated elevated CD4 T cell counts in the lymphocyte gate, suggesting leukemic changes, typical of AITL. Sakai et al (4) described a case of a patient with AITL, with plasmacytosis in the peripheral blood and leukemic changes, which is similar to the findings in the present case. Baseggio et al (17) attempted to detect T cells expressing CD10 in the peripheral blood of patients with AITL. In each of the 6 cases examined, the authors observed the presence of T cells expressing CD10 in the peripheral blood (mean percentage, 17%; range, 5-58%), while T cells in the control group were CD10 -, suggesting that lymphoma cells appear in the peripheral blood of patients with AITL to varying degrees.
In the present case, CD10 was negative, while c-Maf was positive, in lymphoma cells. A previous study reported that CD10 was detected in 39% of cases of AITL, suggesting that CD10 may a useful diagnostic tool in AITL, although it is neither particularly sensitive, nor specific to this disease (18) . Furthermore, Murakami et al (19) reported that c-Maf may also be a useful marker of AITL. They reported that c-Maf expression was observed in 23 of 31 cases of AITL; 3 of 11 cases of adult T-cell leukemia/lymphoma; 4 of 19 cases of peripheral T-cell lymphoma, unspecified; 0 of 11 cases of mycosis fungoides; 0 of 11 cases of anaplastic large cell lymphoma; and 1 of 10 cases of extranodal NK/T-cell lymphoma, nasal type. Therefore, c-Maf appears to be relatively specifically expressed in AITL.
As previously described, AITL patients tend to be diagnosed at an advanced stage of disease. In the patient reported here, lymphoid cells with atypical nuclei were observed in the lymph node biopsy, and the peripheral blood and bone marrow at presentation. Furthermore, splenomegaly with infarction was detected, suggesting involvement of the spleen. These results suggest that the patient was at stage IV in the Ann Arbor staging system.
The current case report discussed the case of a patient with AITL, presenting with hypergammaglobulinemia, plasmacytosis, leukemic change, and clonal rearrangement of Ig and TCR. A diagnosis of AITL should be considered when encountering patients with polyclonal hypergammaglobulinemia and/or plasmacytosis.
